000			01962 a2200565 4500
005			20250517003902.0
264		0	_c20151020
008			201510s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.2647 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Xiao-Kun
245	0	0	_aAfatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivo. _h[electronic resource]
260			_bOncotarget _cDec 2014
300			_a11971-85 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aATP Binding Cassette Transporter, Subfamily G, Member 2
650	0	4	_aATP-Binding Cassette Transporters _xantagonists & inhibitors
650	0	4	_aAfatinib
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aBlotting, Western
650	0	4	_aCell Line, Tumor
650	0	4	_aDrug Resistance, Multiple _xdrug effects
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aIn Vitro Techniques
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aNeoplasm Proteins _xantagonists & inhibitors
650	0	4	_aNeoplasms, Experimental _xdrug therapy
650	0	4	_aQuinazolines _xpharmacology
650	0	4	_aReal-Time Polymerase Chain Reaction
650	0	4	_aTopotecan _xpharmacology
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aTo, Kenneth Kin Wah
700	1		_aHuang, Li-Yan
700	1		_aXu, Jing-Hong
700	1		_aYang, Ke
700	1		_aWang, Fang
700	1		_aHuang, Zhen-Cong
700	1		_aYe, Sheng
700	1		_aFu, Li-Wu
773	0		_tOncotarget _gvol. 5 _gno. 23 _gp. 11971-85
856	4	0	_uhttps://doi.org/10.18632/oncotarget.2647 _zAvailable from publisher's website
999			_c24392078 _d24392078